[1] Finn RS, Crown JP, Lang I, et al. Thecyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozoleversus letrozole alone as first-line treatment of oestrogen receptor-positive,HER2-negative, advanced breast cancer (...
Cristofanilli M, Rugo HS, Im SA, et al. Overall Survival With Palbociclib And Fulvestrant in Women With HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-Blind, Phase 3 Randomized Study. Clin Cancer Res. 2022 May 12;clincanres.0305.2022. doi: 10.1158/1078-0432.CCR-22-...
Thecyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozoleversus letrozole alone as first-line treatment of oestrogen receptor-positive,HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2study. Lancet Oncol. 2015. 16(1): 25-35. [2] /record/...
[1] Finn RS, Crown JP, Lang I, et al. Thecyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozoleversus letrozole alone as first-line treatment of oestrogen receptor-positive,HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2study. Lancet Onc...
3. HOW IS YOUR PERSONAL DATA COLLECTED? We use different methods to collect data from and about you including through: Your interactions with us.You may give us your Personal Data by filling in online forms or by corresponding with us by post, phone, text, email, direct messages through th...
In the PALOMA-3 study, the combination of the CDK4 and CDK6 inhibitor palbociclib and fulvestrant was associated with significant improvements in progression-free survival compared with fulvestrant plus placebo in patients with metastatic breast cancer. Identification of patients most suitable for the ad...
Johnston S et al. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer NPJ Breast Cancer. 2019 Jan 17;5:5. Verzenios Eu smPC. Hortobagyi G, et al. Ribociclib as First-Line Therapy for HR-Posit...
P373373. Learn Portuguese Business Language in 20 Minutes 19:23 P374374. How to Be an Effective Portuguese Speaker in 15 Minutes 14:03 P375375. Why Your Worst Days Are The Best Days To Study Portuguese December Review 06:18 P376376. Phrases to Study on Your Flight to Brazil 1:01:13...
参考文献: Natasha Leighl,et al.Subcutaneous amivantamab administered every 4 weeks (Q4W) in patients with advanced solid malignancies: The phase Ib PALOMA study . 2024 ELCC:6MO. 责任编辑|KOP
1 文献来源Zhong WZ,Wu YL,Chen KN,et al.CTONG 1103:Erlotinib versus Gemcitabine plus Cisplatin as neoadjuvant treatment for stage ⅢA-N2 EGFR-mutation positive non-small-cell lung cancer (EMERGING):A randomised study [J].Ann Oncol,2018,29(8S):LBA48_PR.2证据水平1b.3背景·ⅢA-N2期非小细...